NWAM LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
NWAM LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$57,000
-28.8%
16,0000.0%0.00%
-33.3%
Q4 2021$80,000
-30.4%
16,0000.0%0.01%
-40.0%
Q3 2021$115,000
-23.3%
16,000
-1.2%
0.01%
-28.6%
Q2 2021$150,000
+2.7%
16,200
+3.2%
0.01%
-6.7%
Q1 2021$146,000
+9.8%
15,700
+4.7%
0.02%0.0%
Q4 2020$133,000
+14.7%
15,000
+50.0%
0.02%
-21.1%
Q3 2020$116,000
-57.4%
10,000
-1.0%
0.02%
-50.0%
Q2 2020$272,00010,1000.04%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders